- Mendus announces request for conversion of convertible bonds by Negma Group
- Mendus tillkännager begäran från Negma Group om konvertering av konvertibla skuldebrev
- Mendus AB: Mendus to present positive interim data from the ALISON trial in ovarian cancer at the AACR Annual Meeting 2023
- Mendus AB: Mendus presenterar positiva interimsdata från ALISON-studien i äggstockscancer vid AACR 2023
- Mendus AB: Mendus announces request for conversion of convertible bonds by Negma Group
- Mendus AB: Mendus tillkännager begäran från Negma Group om konvertering av konvertibla skuldebrev
- Mendus AB: Mendus säkrar ett andra aktieägarlån från Van Herk Investment och minskar antalet utestående konvertibla obligationer till Negma Group
- Mendus AB: Mendus secures second shareholder loan from Van Herk Investments and reduces the number of outstanding convertible bonds with Negma Group
- Mendus AB: Mendus deltar i följande konferenser i mars 2023
- Mendus AB: Mendus to participate in upcoming conferences in March 2023
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.23 |
---|---|
High | 1.28 |
Low | 1.15 |
Bid | -- |
Offer | -- |
Previous close | 1.24 |
Average volume | 296.24k |
---|---|
Shares outstanding | 199.40m |
Free float | 83.44m |
P/E (TTM) | -- |
Market cap | 246.86m SEK |
EPS (TTM) | -0.7006 SEK |
Data delayed at least 15 minutes, as of Mar 28 2023 17:00 BST.
More ▼